Amitriptyline modifies the visceral hypersensitivity response to acute stress in the irritable bowel syndrome

Alimentary Pharmacology and Therapeutics

Volumn 29, Issue 5, 2009, Pages 552-560

  Thoua, N M ^a   Murray, C D R ^b   Winchester, W J ^c   Roy, A J ^a   Pitcher, M C L ^d   Kamm, M A ^d   Emmanuel, A V ^a  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

^d ST MARK S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE;

ACUTE STRESS; ADULT; ARTICLE; AUTONOMIC INNERVATION; BLOOD FLOW; BLOOD PRESSURE; CLINICAL ARTICLE; COLD PRESSOR TEST; DIZZINESS; DROWSINESS; DRUG DOSE INCREASE; DRUG EFFICACY; ELECTROSTIMULATION; FEMALE; HEADACHE; HEART RATE; HUMAN; IRRITABLE COLON; MALE; OPEN STUDY; PAIN THRESHOLD; PHYSICAL STRESS; PRIORITY JOURNAL; RECTUM MUCOSA; RESTLESSNESS; VISCERA;

ADULT; AMITRIPTYLINE; ANALGESICS, NON-NARCOTIC; FEMALE; HUMANS; HYPERSENSITIVITY; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PAIN MEASUREMENT; PAIN THRESHOLD; RECTUM; STATISTICS AS TOPIC; VISCERA; YOUNG ADULT;

EID: 59149095406     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2008.03918.x     Document Type: Article

References (34)

1. Kay L, Jorgensen T, Jensen KH. The epidemiology of irritable bowel syndrome in a random population prevalence, incidence, natural history and risk factors. J Intern Med 1994 236 : 23 30.
2. Drossman DA. Review article: an integrated approach to the irritable bowel syndrome. Aliment Pharmacol Ther 1999 13 (Suppl.2 3 14.
3. Camilleri M, Coulie B, Tack JF. Visceral hypersensitivity facts, speculations, and challenges. Gut 2001 48 : 125 31.
4. Stam R, Akkermans LM, Wiegant VM. Trauma and the gut interactions between stressful experience and intestinal function. Gut 1997 40 : 704 9.
5. Creed F, Ratcliffe J, Fernandez L, et al. Health-related quality of life and healthcare costs in severe, refractory irritable bowel syndrome. Ann Intern Med 2001 134 : 860 8.
6. Creed F, Ratcliffe J, Fernandez L, et al. North of England IBS Research Group, Outcome in severe irritable bowel syndrome with and without accompanying depressive, panic and neurasthenic disorders. Br J Psychiatry 2005 186 : 507 15.
7. Stam R, Croiset G, Akkermans LM, Wiegant VM. Sensitization of the colonic response to novel stress after previous stressful experience. Am J Physiol 1996 271 : R1270 3.
8. Rao SS, Hatfield RA, Suls JM, Chamberlain MJ. Psychological and physical stress induce differential effects on human colonic motility. Am J Gastroenterol 1998 93 : 985 90.
9. Dickhaus B, Mayer EA, Firooz N, et al. Irritable bowel syndrome patients show enhanced modulation of visceral perception by auditory stress. Am J Gastroenterol 2003 98 : 135 43.
10. Murray CDR, Flynn J, Ratcliffe L, Jacyna MR, Kamm MA, Emmanuel AV. Effect of acute physical and psychological stress on gut autonomic innervation in irritable bowel syndrome. Gastroenterology 2004 127 : 1695 703.
11. Jackson JL, O'Malley PG, Tompkins G, Balden E, Santoro J, Kruenke K. Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med 2000 108 : 65 72.
12. Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE. Rome II. The Functional Gastrointestinal Disorders. Diagnosis, Pathophysiology and Treatment: A Multinational Consensus, 2nd edn. VA : Degnon Associates Inc, McLean, 2000.
13. Francis CY, Duffy JN, Whorwell PJ, Morris J. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997 11 : 395 402.
14. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983 67 : 361 70.
15. O'Brien JD, Thompson DG, Burnham WR, Holly J, Walker E. Action of centrally mediated autonomic stimulation on human upper gastrointestinal transit a comparative study of two stimuli. Gut 1987 28 : 960 9.
16. Emmanuel AV, Kamm MA. Laser Doppler measurement of rectal mucosal blood flow. Gut 1999 45 : 64 9.
17. Emmanuel AV, Kamm MA. Laser Doppler flowmetry as a measure of extrinsic colonic innervation in functional bowel disease. Gut 2000 46 : 212 7.
18. Kamm MA, Lennard-Jones JE. Rectal mucosal electrosensory testing - evidence for a rectal sensory neuropathy in idiopathic constipation. Dis Colon Rectum 1990 33 : 419 23.
19. Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995 109 : 40 52.
20. Chey WY, Jin HO, Lee MH, Sun SW, Lee KY. Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea. Am J Gastroenterol 2001 96 : 1499 506.
21. Poitras P, Poitras MR, Plourde V, Boivin M, Verrier P. Evolution of visceral sensitivity in patients with irritable bowel syndrome. Dig Dis Sci 2002 47 : 914 20.
22. Talley NJ. Review article: 5-Hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation. Aliment Pharmacol Ther 1992 6 : 273 89.
23. Scarpignato C, Pelosini I. Management of irritable bowel syndrome: Novel approaches to the pharmacology of gut motility. Can J Gastroenterol 1999 13 (suppl 50 65A.
24. Talley NJ. Pharmacologic therapy for irritable bowel syndrome. Am J Gastroenterol 2003 98 : 750 8.
25. Jailwalla J, Imperiale TF, Kroenke K. Pharmacologic treatment of the irritable bowel syndrome: a systematic review or randomised controlled trials. Ann Int Med 2000 133 : 136 47.
26. Morgan V, Pickens D, Kessler R, Mertz H. Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome. Gut 2005 54 : 569 73.
27. Mertz H, Morgan V, Tanner G, et al. Regional cerebral activation in IBS and controls with painful and non-painful rectal distension. Gastroenterology 2000 118 : 842 8.
28. Gorelick AB, Koshy SS, Hooper FG, et al. Differential effects of amitriptyline on perception of somatic and visceral stimulation in healthy humans. Am J Physiol 1998 38 : G460 6.
29. Nozu T, Kudaira M. Corticotropin-releasing factor induces rectal hypersensitivity after repetitive painful rectal distention in healthy humans. J Gastroenterol 2006 41 : 740 4.
30. Sagami Y, Shimada Y, Tayama J, et al. Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome. Gut 2004 53 : 958 64.
31. Saito K, Kasai T, Nagura Y, Ito H, Kanazawa M, Fukudo S. Corticotropin-releasing hormone receptor 1 antagonist blocks brain-gut activation induced by colonic distention in rats. Gastroenterology 2005 129 : 1533 43.
32. Million M, Grigoriadis DE, Sullivan S, et al. A novel water-soluble selective CRF1 receptor antagonist, NBI 35965, blunts stress-induced visceral hyperalgesia and colonic motor function in rats. Brain Res 2003 985 : 32 42.
33. Naliboff BD, Berman S, Suyenobu B, et al. Longitudinal change in perceptual and brain activation response to visceral stimuli in irritable bowel syndrome patients. Gastroenterol 2006 131 : 352 65.
34. Clouse RE, Lustman PJ, Geisman RA, et al. Antidepressant therapy in 138 patients with irritable bowel syndrome: A five-year clinical experience. Aliment Pharmacol Ther 1994 8 : 409 16.